Clinical Trials Browser

Phase 1/2 × Neuroblastoma × MLN 8237 × Clear all

NCT01601535 2019-07-31

Study of MLN8237 in Combination With Irinotecan and Temozolomide

Phase 1/2 Completed

54 enrolled 25 charts

Neuroblastoma